Endogenous fungal endopthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: A case report.
Indian J Ophthalmol
; 69(12): 3759-3761, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1538649
ABSTRACT
We present a case of endogenous fungal endophthalmitis in a nondiabetic, nonhypertensive patient who recovered from COVID-19 infection. Endogenous fungal endophthalmitis in an immunocompetent individual is quite uncommon. The organism in our patient was resistant to amphotericin and voriconazole and was successfully treated with intravitreal caspofungin. The rarity of an opportunistic nosocomial infection in an immunocompetent person with a drug-resistant organism prompted us to write this report.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Eye Infections, Fungal
/
Endophthalmitis
/
COVID-19
Type of study:
Case report
/
Diagnostic study
Limits:
Humans
Language:
English
Journal:
Indian J Ophthalmol
Year:
2021
Document Type:
Article
Affiliation country:
Ijo.IJO_1192_21
Similar
MEDLINE
...
LILACS
LIS